secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiniksa Pharmaceuticals International, plc (KNSA)
CIK:        0001730430
Form:       8-K
Filed at:   2025-09-03T23:59:59+00:00
Accession:  0001104659-25-086689
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiniksa posts September 2025 investor presentation, no material new information disclosed
--------------------------------------------------------------------------------

- Investor presentation posted on investors.kiniksa.com on September 3, 2025.
- Presentation expected to be used in meetings with investors and analysts.
- No financial results, guidance, or specific corporate events announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730430/000110465925086689/0001104659-25-086689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730430/000110465925086689/tm2525025d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-086689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer